泰利霉素是半合成大环内酯一林可酞胺一链阳菌素B (MLSB)家族中的第一个抗菌药物。
酮内酯中最具代表性的药物泰利霉素已于2001年成功上市，其对包括大环内酯耐药菌在内的革兰氏阳性菌具有良好的抗菌活性。
Telithromycin, which is the representative of ketolides, has come into market in 2001. It shows very good activity against some macrolide-resistant bacteria.
治疗均用强力霉素、氯霉素、泰利必妥等，2例因多脏器功能衰竭死亡，治愈率98.2 %。
The healing rate was 98.2%. Only 2 cases died of multi organ failure in use of chloromycetin, doxycycline, ofloxacin et al.
应用推荐